EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies Post author:Sam Post published:April 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Actelion Provides An Update On The Progress Towards Launching – Key Results For Pipeline Assets To Be Developed By May 21, 2017 How We Talk about Science and Science Denial November 14, 2017 Antibe Therapeutics Announces Closing Of Public Offering June 20, 2017
Actelion Provides An Update On The Progress Towards Launching – Key Results For Pipeline Assets To Be Developed By May 21, 2017